FREMONT, Calif., June 8 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) today announced that it will present at the Goldman Sachs 26th
Annual Healthcare Conference on Tuesday, June 14, 2005 at 10:25 a.m. PT, 1:25
p.m. ET. The presentation will be webcast live and may be accessed by
visiting the Abgenix website at http://www.abgenix.com. A replay of the webcast will
also be available on the company's website until Tuesday, June 28, 2005.
Bill Ringo, president and chief executive officer of Abgenix, will provide
an overview of the company's antibody development activities.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of human therapeutic antibodies. The company's
antibody development platform includes a leading technology and state-of-the-
art manufacturing capabilities that enable the rapid generation, selection and
production of high affinity, fully human antibody product candidates to a
variety of disease targets. Abgenix leverages its leadership position in human
antibody technology to build a diversified product portfolio through its own
development efforts and the establishment of collaborations with multiple
pharmaceutical and biotechnology companies. For more information on Abgenix,
visit the company's website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Aisha Santiago, Corporate Communications &
Investor Relations of Abgenix, Inc., +1-510-284-6858 or
+1-510-284-6605; or E. Blair Schoeb, Corporate Communications,
+1-917-432-9275, for Abgenix, Inc.
|
